New Release Integrates Calculators, Priors, and Clinical Guidance to Generate Preliminary Reports Automatically
CHICAGO, Nov. 19, 2025 /PRNewswire/ — Imorgon today announced Imorgon v2, an upgrade to its structured reporting platform designed to reduce non-interpretive workload for radiologists, sonographers, and technologists. The new version processes measurements and observations as structured findings and transfers them into a preliminary report for the radiologist.
Imorgon v2 achieves these efficiencies through enhancements to its reporting engine, including prior-measurement retrieval, integrated calculators, clinical decision support, and automated text generation. Together, these capabilities produce a preliminary report that reduces manual steps and enables radiologists to focus on interpretation.
Key enhancements include:
“Productivity gains don’t require future AI breakthroughs,” said Andy Milkowski, CEO of Imorgon. “Imorgon v2 applies practical automation to the routine steps that slow radiologists down, ensuring they can dictate less and do more.”
Early users report immediate efficiency improvements.
Lynn C, Director of Clinical Applications, noted, “Automated transfer of measurements and findings allowed our team to spend less time on manual entry and more time on accurate diagnosis.”
Visit Imorgon at RSNA 2025, South Hall, Booth 2060.
About Imorgon
Imorgon develops software that improves radiology reporting efficiency and diagnostic quality by eliminating non-interpretive work and streamlining workflow. Learn more at www.imorgon.net.
Click here for more details about our booth at: https://rsna2025.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=00559058.
SOURCE Imorgon Medical
LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the…
A summary of the current discussions in consumer health and wellness on the topic of…
LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope…
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal…